The selective D1/D5 agonist significantly improved Parkinson’s disease motor symptoms, with low rates of somnolence and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results